These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6357548)

  • 21. Evidence that matching for HLA antigens significantly increases transplant survival in 1001 renal transplants performed in the northwest region of England.
    Dyer PA; Johnson RW; Martin S; Bakran A; Gokal R; Harris R; Mallick NP; Manos J; Orr WM; Pearson RC
    Transplantation; 1989 Jul; 48(1):131-5. PubMed ID: 2665219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of HLA-A,B and DR antigens on cadaver kidney transplantation in the Japanese.
    Ohmori K; Yokoyama T; Kashiwabara H
    Transplant Proc; 1983 Dec; 15(4):2142-4. PubMed ID: 6369683
    [No Abstract]   [Full Text] [Related]  

  • 23. HLA-DR matching: the impact on cadaveric renal transplantation. A single-center study.
    Madsen M; Graugaard B; Fjeldborg O; Posborg V; Hansen HE; Lamm LU; Kissmeyer-Nielsen F
    Scand J Urol Nephrol Suppl; 1981; 64():56-63. PubMed ID: 6815794
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term follow-up in London Transplant Group recipients of cadaver renal allografts. The influence of HLA matching on transplant outcome.
    Festenstein H; Doyle P; Holmes J
    N Engl J Med; 1986 Jan; 314(1):7-14. PubMed ID: 3510010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-A, -B, and -DR matching and preoperative transfusions in renal transplantation.
    Reinitz ER; Rhodes C; Ellis T; Goldman MH; Bacquero A; Mendez-Picon G; Lee HM; Carter WH; Mohanakumar T
    Transplant Proc; 1984 Dec; 16(6):1415-8. PubMed ID: 6390840
    [No Abstract]   [Full Text] [Related]  

  • 26. HLA-A antigen incompatibility and HLA-B antigen compatibility associated with enhanced kidney allograft survival in blood-transfused patients.
    Bućin D
    Exp Clin Immunogenet; 1986; 3(3):138-44. PubMed ID: 3274633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of HLA matching on graft survival in live donor kidney transplantations.
    Velidedeoğlu E; Bilgin N; Haberal M
    Transplant Proc; 1993 Dec; 25(6):3144-5. PubMed ID: 8266491
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of zero HLA class I and II mismatching in cyclosporine-treated kidney transplant patients.
    Cicciarelli J; Terasaki PI; Mickey MR
    Transplantation; 1987 May; 43(5):636-40. PubMed ID: 3554654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DR typing in cadaver kidney donors and recipients in Copenhagen.
    Thomsen M; Astrup L; Jakobsen B; Morling N; Platz P; Ryder LP; Svejgaard A; Løkkegaard H; Ladefoged J; Thaysen JH
    Scand J Urol Nephrol Suppl; 1981; 64():79-86. PubMed ID: 6815796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical importance of HLA antigen matching in cadaveric kidney transplantation with high overall survival rates. The Manchester UK Kidney Transplant Team.
    Dyer PA; Martin S; Johnson RW
    Transplant Proc; 1992 Dec; 24(6):2454. PubMed ID: 1465827
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of HLA antigens of renal transplant recipients on graft survival.
    Alamartine E; Berthoux F; Acquart S; Lepetit JC
    Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
    [No Abstract]   [Full Text] [Related]  

  • 32. Strength of HLA-A, HLA-B, and HLA-DR mismatches in relation to short- and long-term kidney graft survival. Collaborative Transplant Study.
    Opelz G
    Transpl Int; 1992; 5 Suppl 1():S621-4. PubMed ID: 14628741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arguments against HLA-A, -B, -DR mismatching in kidney transplant recipients.
    Cicciarelli J; Terasaki P
    Transplant Proc; 1989 Feb; 21(1 Pt 1):659-60. PubMed ID: 2650213
    [No Abstract]   [Full Text] [Related]  

  • 34. Survival of serologically HLA typed and matched cadaveric kidney transplants and patients: influence of serologic retyping of donors.
    Thorogood J; Doxiadis II; Schreuder GM; Persijn GG; van Rood JJ
    Transplant Proc; 1993 Dec; 25(6):3051-2. PubMed ID: 8266449
    [No Abstract]   [Full Text] [Related]  

  • 35. Renal transplantation in Australia and New Zealand, 1963-1982: report from the ANZ Data Registry.
    Disney A
    Transplant Proc; 1984 Aug; 16(4):973-8. PubMed ID: 6380061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial HLA matching.
    Gilks WR; Bradley BA; Gore SM
    Lancet; 1986 Mar; 1(8479):509. PubMed ID: 2869251
    [No Abstract]   [Full Text] [Related]  

  • 37. Improved kidney graft survival through HLA-DR-MT matching.
    Müller GA; Müller C; Wernet P
    Proc Eur Dial Transplant Assoc; 1983; 19():464-8. PubMed ID: 6348746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Taboo HLA mismatches in cadaveric renal transplantation: definition, analysis, and possible implications.
    Doxiadis II; Smits JM; Stobbe I; Schreuder GM; Persijn GG; van Houwelingen H; van Rood JJ; Claas FH
    Transplant Proc; 1996 Feb; 28(1):224. PubMed ID: 8644189
    [No Abstract]   [Full Text] [Related]  

  • 39. Reliability of HLA typing on peripheral blood lymphocytes in cadaveric organ donors and the impact of blank donor antigens on kidney graft survival.
    Offermann G; Bünte S; Angelides U; Geidner U; Kirschbaum B; Müller E; Wendt N
    Transplant Proc; 1992 Dec; 24(6):2488-9. PubMed ID: 1361261
    [No Abstract]   [Full Text] [Related]  

  • 40. Proposed HLA matching scheme for improved cadaveric kidney allocation.
    Terasaki PI; Gjertson DW; Cecka JM; Takemoto S
    Transplant Proc; 1995 Feb; 27(1):61-3. PubMed ID: 7879117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.